PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

#mhra

Tag

Posts navigation

1 2 3 Next
MHRA consults on ending EC Decision Reliance Procedure

MHRA consults on ending EC Decision Reliance Procedure

The Medicines and Healthcare products Regulatory Agency (MHRA) is inviting feedback on plans to end use of the European Commission Decision Reliance Procedure (ECDRP) to bring medicines to market.

4 Sep 2023
Read More
Clarification on continuation of CE marking in UK

Clarification on continuation of CE marking in UK

The UK’s Department for Business and Trade (DBT) has announced an indefinite extension to the use of CE marking for businesses in the UK, beyond the 2024 deadline. The aim is to cut business costs and products’ time to market. The government intends to implement major reforms to the current regulatory framework for medical devices, with core parts set to apply from 1 July 2025.

7 Aug 2023
Read More
MHRA publishes annual report for 2022-2023

MHRA publishes annual report for 2022-2023

The UK Medicines and Healthcare products Regulatory Agency’s (MHRA) annual report and accounts for 2022-2023 was printed on 19 July 2023. The report outlines achievements during the year, such as its evolution into a ‘One Agency’ organisation, uniting its regulatory, research and standards and clinical data service.

31 Jul 2023
Read More
Why we need Medical Affairs 3.0

Why we need Medical Affairs 3.0

New biotechs and small pharma companies find it hard to take their products from discovery to market because of a lack of capital and early-stage expertise. Dr Malcolm Barratt-Johnson, PharmaMedic Consultancy’s Managing Director, says the traditional routes do not work and offers a plan to help innovators move their products forward.

24 Jul 2023
Read More
MHRA announces corporate plan for 2023-2026

MHRA announces corporate plan for 2023-2026

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has published its corporate plan for the next three years, featuring a focus on patient access to innovation.

17 Jul 2023
Read More
Pharma conference examines MHRA, VPAS, staffing and real estate needs

Pharma conference examines MHRA, VPAS, staffing and real estate needs

Four important themes for the life sciences were the focus of the Professional Industry Network Group (PING) conference, held in June 2023. These included the position of the Medicines and Healthcare products Regulatory Agency (MHRA) post the COVID-19 pandemic, the implications of the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) and the proposed Voluntary Scheme for Pricing, Access and Growth (VPAG), plus whether there were adequate staffing and premises to support the sector.

4 Jul 2023
Read More
The O’Shaughnessy report: how to boost clinical trials in the UK

The O’Shaughnessy report: how to boost clinical trials in the UK

The much anticipated O’Shaughnessy report examining commercial clinical trials in the UK was published at the end of May 2023. Its findings have prompted the UK government to initiate a series of actions, in response to its 27 recommendations, that are designed to make the UK a world leader in this important part of the life sciences industry.

26 Jun 2023
Read More
Windsor Framework measures start 1 January 2025

Windsor Framework measures start 1 January 2025

The government has announced that new measures laid out in the Windsor Framework regarding the supply of medicines to Northern Ireland will commence from 1 January 2025. This extends the previous deadline for compliance, which was 31 December 2023.

19 Jun 2023
Read More
MHRA consults public on ICH Good Clinical Practice guideline

MHRA consults public on ICH Good Clinical Practice guideline

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is inviting public feedback on the Good Clinical Practice (GCP) guideline revised by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

15 Jun 2023
Read More
MHRA announces international partnerships to accelerate medicines approvals

MHRA announces international partnerships to accelerate medicines approvals

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced a new international framework that will help bring new medicines to patients faster.

8 Jun 2023
Read More

Posts navigation

1 2 3 Next

Categories

  • Awards
  • Consultants
  • Events
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #BIA #cancer #ClinicalTrials #drugapprovals #drugpricing #drugregulation #EC #EFPIA #EMA #EU #FDA #HorizonEurope #HTA #innovation #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicinesaccess #medtech #mentalhealth #mhra #NHS #NICE #patients #pharmaregulation #pre-eclampsia #R&D #rarediseases #regulation #regulatory #research #startups #UKgovernment #ukpharma #ukregulation #VPAS AI Biotech COVID-19 Healthcare medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital